BAM
GWPH

Bruderman Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bruderman Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-90
Closed -$15K – 631
2019
Q1 		$15K Hold
90
– – ﹤0.01% 398
2018
Q4 		$9K Buy
+90
New +$11.8K ﹤0.01% 449

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Bruderman Asset Management's GWPH Position: Q2 2019 in Review

Bruderman Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 90 shares — an estimated $15K sold.

Bruderman Asset Management first reported a position in GWPH in Q4 2018 and held it in 2 quarters. The position peaked at $15K in Q1 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

  • Bruderman Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Bruderman Asset Management sold 90 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $15K.
  • Bruderman Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 2 quarters.
  • Bruderman Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $15K in Q1 2019.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.